SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

18 Aug 2021 07:00

RNS Number : 9502I
Rotork PLC
18 August 2021
 

Rotork Plc ("Rotork")

 

Share Buy-Back Programme

 

18 August 2021

 

As announced at the interim results on 3 August 2021, Rotork plc ('Rotork' or the 'Company') remains a highly cash generative business with a strong cash position that provides us with considerable financial flexibility. Consistent with our capital allocation policy, the Board has decided to return a prudent level of cash to shareholders while retaining a strong balance sheet. As a result, Rotork announces that it is commencing a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares'). The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £50 million (excluding stamp duty and expenses). Any Ordinary Shares purchased by the Company will be cancelled. This decision in no way reduces our appetite to pursue strategic investments and we remain active in looking for suitable opportunities.

 

The first tranche of the Programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ('JPM'), pursuant to which JPM shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The first tranche of the Programme will run from 19 August 2021 and end no later than 30 September 2021. The aggregate purchase price of all Ordinary Shares acquired under the first tranche of the Programme will be no greater than £20 million (excluding stamp duty and expenses). The maximum number of Ordinary Shares that can be purchased under the first tranche of the Programme is 8 million Ordinary Shares (based on authority granted at the Company's 2021 Annual General Meeting of 87.4 million Ordinary Shares). JPM will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company.

 

Any purchase of Ordinary Shares under the first tranche of the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its 2021 Annual General Meeting, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0) 203 727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Notes:

Legal Entity Identity: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQDLFFFVLFBBX
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.